Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Intrexon Corp. (NYSE: XON).

Full DD Report for XON

You must become a subscriber to view this report.


Recent News from (NYSE: XON)

New Research: Key Drivers of Growth for Intrexon, Graham, The Walt Disney, Toyota Motor, Atlas Air Worldwide, and SITO Mobile - Factors of Influence, Major Initiatives and Sustained Production
NEW YORK, Nov. 30, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Intrexon Corporation (NASDAQ:XON), Graham Holdings Company (NYSE:GHC), Th...
Source: GlobeNewswire
Date: November, 30 2018 07:35
Notable earnings after Thursday's close
AGO , AL , ALTR , AMBR , AMC , AMPH , AQN , ARRS , ASRT , ATVI , BOJA , BPI , BRS , BW , CBPX , COLD , COLL , CTL , CYRX , DBX , DIS , DOX , ECOM , EGAN , EPAY , ERI , FGEN , FOE , FSCT , FSM , FTCH , GMED , HDP , HTZ , ICUI , JAG , JJSF , LGF.A , LOPE...
Source: SeekingAlpha
Date: November, 07 2018 17:35
AquaBounty Technologies, Inc. Results for the quarter and nine months ended September 30, 2018
MAYNARD, Mass., Nov. 02, 2018 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. (NASDAQ: AQB) (“AquaBounty” or the “Company”), a biotechnology company focused on enhancing productivity in the aquaculture market and a majority-owned subsidiary of Intrexon Corporat...
Source: GlobeNewswire
Date: November, 02 2018 07:30
Lifshitz & Miller LLP Announces Investigation of Access National Corporation, Engility Holdings, Inc., Floor & Decor Holdings, Inc., Global Blood Therapeutics, Inc., Intrexon Corporation, Keryx Biopharmaceuticals, Inc., Nevada Gold & Casinos, Inc., and So
NEW YORK , Nov. 1, 2018 /PRNewswire/ -- Access National Corporation (ANCX) Lifshitz & Miller  announces investigation into possible breaches of fiduciary duties in connection with the sale of ANCX to Union Bankshares Corporation for 0.75 shares of Union common stock per...
Source: PR Newswire
Date: November, 01 2018 15:37
Intrexon to Announce Third Quarter 2018 Financial Results on November 8th
GERMANTOWN, Md. , Nov. 1, 2018 /PRNewswire/ --   Intrexon Corporation (NASDAQ: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced it will release third quarter 2018 financial results after the ...
Source: PR Newswire
Date: November, 01 2018 07:30
Bragar Eagel & Squire, P.C. is Investigating Intrexon Corporation (XON) on Behalf of Stockholders and Encourages XON Investors to Contact the Firm
NEW YORK, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against Intrexon Corporation (NASDAQ: XON).  Our investigation concerns whether Intrexon has violated the federal securities laws and/or engaged in other unlawful business prac...
Source: GlobeNewswire
Date: October, 29 2018 17:13
ActoBio Therapeutics(TM) Doses First Patient in Phase Ib/IIa Clinical Study of AG019 for the Treatment of Type 1 Diabetes
GHENT, Belgium, Oct. 29, 2018 /PRNewswire/ --  ActoBio Therapeutics, Inc. , a wholly owned subsidiary of Intrexon Corporation (NASDAQ: XON) and innovative clinical-stage biotechnology company focused on a new class of microbe-based therapeutic agents, and Intrexon T1D Partners LL...
Source: PR Newswire
Date: October, 29 2018 07:30
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Intrexon Corporation (XON)
NEW YORK, NY / ACCESSWIRE / October 25, 2018 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Intrexon Corporation(''Intrexon'' or the ''Company'') (NYSE: XON).Such investors are encouraged to obtain additional information and assist the ...
Source: ACCESSWIRE IA
Date: October, 25 2018 10:43
Intrexon Announces the Formation of Bioinformatics Hub in Munich
GERMANTOWN, Md. , Oct. 24, 2018 /PRNewswire/ --  Intrexon Corporation (NASDAQ: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced the formation of Intrexon Bioinformatics Germany GmbH, a Munich...
Source: PR Newswire
Date: October, 24 2018 07:30
Report: Exploring Fundamental Drivers Behind Q2, Badger Meter, Tiffany, Walgreens Boots Alliance, Intrexon, and Denali Therapeutics - New Horizons, Emerging Trends, and Upcoming Developments
NEW YORK, Oct. 23, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Q2 Holdings, Inc. (NYSE:QTWO), Badger Meter, Inc. (NYSE:BMI), Tiffany ...
Source: GlobeNewswire
Date: October, 23 2018 08:40

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-1414.6914.5614.81514.41511,215
2017-06-0822.0322.6523.0421.80807,608
2017-06-0721.8022.0222.1421.73552,442
2017-06-0621.7821.9622.2321.531499,106
2017-06-0522.2821.8222.5221.531962,212

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1442,12977,66754.2431Short
2018-12-134,90626,49318.5181Cover
2018-12-127,59050,09415.1515Cover
2018-12-1114,44852,67827.4270Cover
2018-12-1015,95870,00122.7968Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on XON.


About Intrexon Corp. (NYSE: XON)

Logo for Intrexon Corp. (NYSE: XON)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $2,143,695,830 - 05/31/2018
  • Issue and Outstanding: 129,294,079 - 04/30/2018

 


Recent Filings from (NYSE: XON)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: September, 12 2018
Amendment to a previously filed 10-Q
Filing Type: 10-Q/AFiling Source: edgar
Filing Date: August, 13 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 13 2018
Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: August, 13 2018
Notification that form 10-Q will be submitted late
Filing Type: NT 10-QFiling Source: edgar
Filing Date: August, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 09 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: July, 06 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: July, 03 2018
Prospectus filed under Rule 424(b)(5)
Filing Type: 424B5Filing Source: edgar
Filing Date: July, 02 2018
Prospectus filed under Rule 424(b)(5)
Filing Type: 424B5Filing Source: edgar
Filing Date: July, 02 2018

 

 


Daily Technical Chart for (NYSE: XON)

Daily Technical Chart for (NYSE: XON)


Stay tuned for daily updates and more on (NYSE: XON)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NYSE: XON)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in XON is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of XON and does not buy, sell, or trade any shares of XON. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/